Algorae Pharmaceuticals Ltd (LVCLY)
0.0246
-0.01
(-17.73%)
USD |
OTCM |
May 17, 16:00
Algorae Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2019 | 0.0699 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.0016 |
| December 31, 2015 | 0.1509 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2009 | 0.0026 |
| December 31, 2008 | 0.0062 |
| December 31, 2007 | 0.3259 |
| December 31, 2006 | -3.240 |
| December 31, 2005 | 0.0017 |
| June 30, 2005 | 0.00 |
| December 31, 2004 | 0.0014 |
| June 30, 2004 | -0.7894 |
| December 31, 2003 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0699
Minimum
Dec 2019
0.0699
Maximum
Dec 2019
0.0699
Average
0.0699
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 0.00 |
| Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.120M |
| Total Liabilities (Quarterly) | 0.2604M |
| Shareholders Equity (Quarterly) | 1.859M |